insitro, the AI therapeutics company built on causal biology, announced that it has entered into a definitive agreement to acquire CombinAbleAI and launch its...
insitro, a machine learning-powered drug discovery and development company, announced the appointment of S. Michael Rothenberg, M.D., Ph.D., as chief medical officer. In this...